Histopathology

Article	Citations
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction	928
The 2019 World Health Organization classification of tumours of the breast	365
Pulmonary and systemic involvement in COVID‐19 patients assessed with ultrasound‐guided minimally invasive autopsy	234
Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD	155
Third‐trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐positive women: histomorphology, including viral immunohistochemistry and in‐situ hybridization	106
Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours	102
Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies	86
Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID‐19 pneumonia in Wuhan, China	76
Pulmonary pathology of early‐phase COVID‐19 pneumonia in a patient with a benign lung lesion	75
Hunting coronavirus by transmission electron microscopy – a guide to SARS‐CoV‐2‐associated ultrastructural pathology in COVID‐19 tissues	70
NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma	61
Identifying mismatch repair‐deficient colon cancer: near‐perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population‐based series	52
Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases	51
Transarterial chemoembolisation enhances programmed death‐1 and programmed death‐ligand 1 expression in hepatocellular carcinoma	50
When used together SS18–SSX fusion‐specific and SSX C‐terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in	50
Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)	48
Evolving classification of rhabdomyosarcoma	46
Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms*	45
Primary high‐grade non‐anaplastic thyroid carcinoma: a retrospective study of 364 cases	42
Performance of the pattern‐based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma	41
PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna	40
Addition of the tumour–stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma	39
Looking into digestive mixed neuroendocrine – nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors	39
Loss of switch/sucrose non‐fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas	39
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma	38

Updates on spread through air spaces (STAS) in lung cancer	36
An introduction to the WHO 5th edition 2022 classification of testicular tumours	33
Computerised scoring protocol for identification and quantification of different immune cell populations in breast tumour regions by the use of QuPath software	32
The diversity of tumours with microsatellite instability: molecular mechanisms and impact upon microsatellite instability testing and mismatch repair protein immunohistochemistry	31
Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33–RET fusions and BRAF V600E mutations	31
Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei	31
Prognostication for oral squamous cell carcinoma patients based on the tumour–stroma ratio and tumour budding	30
Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features	30
Pleomorphic adenoma: the great mimicker of malignancy	30
Poorly differentiated clusters in colorectal cancer: a current review and implications for future practice	30
Non‐conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia	30
The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real‐time polymerase chain reaction	30
Gastric neuroendocrine tumours from long‐term proton pump inhibitor users are indolent tumours with good prognosis	29
Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical implications	28
Artificial intelligence and algorithmic computational pathology: an introduction with renal allograft examples	27
Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes	27
Head to head: should the intraductal component of invasive prostate cancer be graded?	26
Superficial CD34‐positive fibroblastic tumor and PRDM10‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases	25
Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis	25
Recent advances in the pathology of heritable gastric cancer syndromes	25
Identification of EWSR1–NFATC2 fusion in simple bone cysts	25
Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous lesions in the vulva	25
The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression	25
Gastrointestinal tissue‐based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours	25
Metastasis to the thyroid gland: a single‐institution 16‐year experience	25
Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters	25
Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis	24
An update on the pathological classification of breast cancer	24
Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue	24
Adenomyoepithelioma of the breast: a proposal for classification	24
Undifferentiated endometrial carcinoma arising in the background of high‐grade endometrial carcinoma – Expanding the definition of dedifferentiated endometrial carcinoma	24
COVID‐19 related lung pathology: old patterns in new clothing?	23
The prognostic significance of ALDH1A1 expression in early invasive breast cancer	23
Mesenchymal neoplasms with NTRK and other kinase gene alterations	23
Sry‐related high‐mobility‐group/HMG box 10 (SOX10) as a sensitive marker for triple‐negative breast cancer	23
Medication‐specific variations in morphological patterns of injury in immune check‐point inhibitor‐associated colitis	23
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification	22
Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence‐free survival in stages I–III colore	22
Histopathological diagnosis of tumour deposits in colorectal cancer: a Delphi consensus study	22
Higher densities of tumour‐infiltrating lymphocytes and CD4+ T cells predict recurrence and progression of ductal carcinoma in situ of the breast	22
Hepatocellular adenoma: what we know, what we do not know, and why it matters	21
A multicentre analytical comparison study of inter‐reader and inter‐assay agreement of four programmed death‐ligand 1 immunohistochemistry assays for scoring in triple‐negative breast cancer	21
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms	21
Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability	20
PRAME is a useful marker for the differential diagnosis of melanocytic tumours and histological mimics	20
Development and validation of a supervised deep learning algorithm for automated whole‐slide programmed death‐ligand 1 tumour proportion score assessment in non‐small cell lung cancer	20
MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics	20
New insights into calcifying pseudoneoplasm of the neuraxis (CAPNON): a 20‐year radiological–pathological study of 37 cases	20
Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading	20
Social media in academics and research: 21st‐century tools to turbocharge education, collaboration, and dissemination of research findings	20

Evaluating programmed death‐ligand 1 (PD‐L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study	20
Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma	19
Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas	19
Pulmonary peripheral glandular papilloma and mixed squamous cell and glandular papilloma frequently harbour the BRAF V600E mutation	19
Digital pathology for primary diagnosis of screen‐detected breast lesions – experimental data, validation and experience from four centres	19
Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations	19
Feasibility and accuracy of pathological diagnosis in en‐bloc transurethral resection specimens versus conventional transurethral resection specimens of bladder tumour: evaluation with pT1 substaging	19
Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor‐1 and neuroendocrine markers	18
Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients	18
Non‐conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum	18
Diagnostic variability in the histopathological assessment of advanced colorectal adenomas and early colorectal cancer in a screening population	18
Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies	18
Hereditary breast cancer: syndromes, tumour pathology and molecular testing	18
The histopathology of congenital haemangioma and its clinical correlations: a long‐term follow‐up study of 55 cases	17
Targeted therapy for upper gastrointestinal tract cancer: current and future prospects	17
Mismatch repair deficiency is rare in bone and soft tissue tumors	17
Taking tumour budding to the next frontier — a post International Tumour Budding Consensus Conference (ITBCC) 2016 review	17
Defining clear cell papillary renal cell carcinoma in routine clinical practice	17
p53 immunohistochemical analysis of fusion‐positive uterine sarcomas	17
Radiation‐associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation†	17
Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy	16
Clinicopathological and molecular characterisation of USP6‐rearranged soft tissue neoplasms: the evidence of genetic relatedness indicates an expanding family with variable bone‐forming capacit	16
Low‐grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity	16
The future of artificial intelligence in digital pathology – results of a survey across stakeholder groups	16
Clinicopathological findings in patients with COVID‐19‐associated ischaemic enterocolitis	16
Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status	16
Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial	16
Mucinous adenocarcinoma arising in congenital pulmonary airway malformation: clinicopathological analysis of 37 cases	16
A case of pericytic neoplasm in the shoulder with a novel DERA–GLI1 gene fusion	16
Colitis‐associated colorectal adenocarcinomas frequently express claudin 18 isoform 2: implications for claudin 18.2 monoclonal antibody therapy	16
Spitz melanocytic tumours – a review	16
Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy	16
PRAME expression in melanocytic lesions of the conjunctiva	16
Histological grading of ovarian mucinous carcinoma – an outcome‐based analysis of traditional and novel systems	16
p16 Immunoexpression in sinonasal and nasopharyngeal adenoid cystic carcinomas: a potential pitfall in ruling out HPV‐related multiphenotypic sinonasal carcinoma	15
Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens	15
Automated assessment of Ki‐67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging	15
Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3‐MAML2 fusions, and clinicopathological features	15
Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies	15
The pathology of gastric and duodenal polyps: current concepts	15
DEVIL, VAAD and vLSC constitute a spectrum of HPV‐independent, p53‐independent intra‐epithelial neoplasia of the vulva	15
Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study	15
Cutaneous histiocytoses in children	15
Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6–NTRK3 fusion, and the rare KLHL7–BRAF fusi	15
Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer	15
Novel APOD–GLI1 rearrangement in a sarcoma of unknown lineage	15
Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas	15
Benign infiltrative myofibroblastic neoplasms of childhood with USP6 gene rearrangement	15
Comparison of different anti‐Ki67 antibody clones and hot‐spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis	15
Gene fusion characterisation of rare aggressive prostate cancer variants—adenosquamous carcinoma, pleomorphic giant‐cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases	15
A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinoma	14
Intratumoral CD103‐positive tumour‐infiltrating lymphocytes are associated with favourable prognosis in patients with triple‐negative breast cancer	14
Elastin in pulmonary pathology: relevance in tumours with a lepidic or papillary appearance. A comprehensive understanding from a morphological viewpoint	14
Advances in the classification of round cell sarcomas	14
Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach	14
Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve‐sparing surgery in prostate cancer patients (NeuroSAFE)	14
Primary de‐differentiated, trans‐differentiated and undifferentiated melanomas: overview of the clinicopathological, immunohistochemical and molecular spectrum	14
Why is the histomorphological diagnosis of tumours of minor salivary glands much more difficult?	14
A novel risk score to predict early and late recurrence in solitary fibrous tumour	14
New insights into the classification of gastric neuroendocrine tumours, expanding the spectrum of ECL‐cell tumours related to hypergastrinaemia	13
Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision	13
Programmed cell death‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) expression in PD‐1 inhibitor‐associated colitis and its mimics	13
Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma	13
Refining the definition of HER2‐low class in invasive breast cancer	13
The role of histopathology in the diagnosis and management of coeliac disease and other malabsorptive conditions	13
Systematic use of fluorescence in‐situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms	13
Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfall	13
Is medullary carcinoma of the colon underdiagnosed? An audit of poorly differentiated colorectal carcinomas in a large national health service teaching hospital	13
Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation	13
Update on triple‐negative breast cancers – highlighting subtyping update and treatment implication	13
‘I Can’t Keep Up!’: an update on advances in soft tissue pathology occurring after the publication of the 2020 World Health Organization classification of soft tissue and bone tumours	13
Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR)	13
Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2‐ rearranged salivary gland tumours	13
PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis	13
Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma	13
Histological features of BRAF V600E‐mutant anaplastic thyroid carcinoma	13
Preservation of Epstein–Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer	13
Visual assessment of mitotic figures in breast cancer: a comparative study between light microscopy and whole slide images	12
Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin‐like enhancer 1 in primary intracranial sarcoma, DICER1‐mutant	12
A rare but devastating cause of twin loss in a near‐term pregnancy highlighting the features of severe SARS‐CoV‐2 placentitis	12

Novel EGFL7–FOSB fusion in pseudomyogenic haemangioendothelioma with widely metastatic disease	12
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study	12
Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management	12
Mesenchymal tumours with RREB1–MRTFB fusion involving the mediastinum: extra‐glossal ectomesenchymal chondromyxoid tumours?	12
Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences	12
Cystic neutrophilic granulomatous mastitis – a review of 12 consecutive cases	12
Interobserver reproducibility of the diagnosis of differentiated exophytic vulvar intraepithelial lesion (DEVIL) and the distinction from its mimics	12
NRAS Q61R immunohistochemical staining in thyroid pathology: sensitivity, specificity and utility	12
The spectrum of serrated colorectal lesions—new entities and unanswered questions	12
Sclerosing stromal tumour: a clinicopathological study of 100 cases of a distinctive benign ovarian stromal tumour typically occurring in the young	12
DNA mismatch repair protein immunohistochemistry – an illustrated guide	12
The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma	12
Pathology updates and diagnostic approaches to haemophagocytic lymphohistiocytosis	12
Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3–MAML2 fusions in salivary gland mucoepidermoid carcinoma	11
A comparative study of Kimura’s disease and IgG4‐related disease: similarities, differences and overlapping features	11
MUC4 is expressed in alveolar rhabdomyosarcoma	11
PRRX1–NCOA1‐rearranged fibroblastic tumour: a clinicopathological, immunohistochemical and molecular genetic study of six cases of a potentially under‐recognised, distinctive mesenchymal tumour	11
Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours	11
Histologic characterization of paediatric mesenchymal neoplasms treated with kinase‐targeted therapy	11
Immunopathology of Kikuchi–Fujimoto disease: A reappraisal using novel immunohistochemistry markers	11
p16 overexpression and Rb loss correlate with high‐risk HPV infection in oropharyngeal squamous cell carcinoma	11
The human‐in‐the‐loop: an evaluation of pathologists’ interaction with artificial intelligence in clinical practice	11
Challenges in Ki‐67 assessments in pulmonary large‐cell neuroendocrine carcinomas*	11
NTRK‐rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation class	11
Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2	11
The important role of the histopathologist in clinical trials: challenges and approaches to tackle them	11
Why did they change that? Practical implications of the evolving classification of neuroendocrine tumours of the gastrointestinal tract	11
What’s new in adipocytic neoplasia?	11
Post‐radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long‐term follow‐up and literature review	11
NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25‐case cohort study	11
Improving Ki67 assessment concordance by the use of an artificial intelligence‐empowered microscope: a multi‐institutional ring study	11
Recent advances in upper gastrointestinal lymphomas: molecular updates and diagnostic implications	11
Gastrointestinal effects of an attempt to avoid contracting COVID‐19 by ‘disinfection’	11
Genomic profile of columnar cell variant of papillary thyroid carcinoma	10
H3F3A‐mutated giant cell tumour of bone without giant cells—clinical presentation, radiology and histology of three cases	10
Comprehensive study of nine novel cases of TFEB‐amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression	10
Development of a semi‐automated method for tumour budding assessment in colorectal cancer and comparison with manual methods	10
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients	10
Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix	10
Programmed death‐ligand 1 expression in human papillomavirus‐independent cervical adenocarcinoma and its prognostic significance	10
Molecular pathology of skin adnexal tumours	10
Lynch syndrome screening in colorectal cancer: results of a prospective 2‐year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2‐million population	10
Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution	10
PTEN expression and morphological patterns in prostatic adenocarcinoma	10
Large cell calcifying Sertoli cell tumour: a contemporary multi‐institutional case series highlighting the diagnostic utility of PRKAR1A immunohistochemistry	10
Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitonea	10
Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP)	10
ALK rearrangements in infantile fibrosarcoma‐like spindle cell tumours of soft tissue and kidney	10
The genetics of vascular tumours: an update	10
Developing consensus in Histopathology: the role of the Delphi method	10
A collaborative workflow between pathologists and deep learning for the evaluation of tumour cellularity in lung adenocarcinoma	10
YAP1–TFE3 gene fusion variant in clear cell stromal tumour of lung: report of two cases in support of a distinct entity	10
Clinicopathological analysis of low‐grade papillary Schneiderian carcinoma: report of five new cases and review of the literature	10
Clinical and histopathological features of pulmonary sclerosing pneumocytoma with dense spindle stromal cells and lymph node metastasis	10
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer	10
Sporadic superficial angiomyxomas demonstrate loss of PRKAR1A expression	10
Clinicopathological, immunohistochemical and fluorescence in‐situ hybridisation features of early subungual melanoma: an analysis of 65 cases	9
The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breast	9
PIN‐like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations	9
Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma	9
Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence	9
RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps	9
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia	9
High interobserver and intraobserver reproducibility among pathologists assessing PD‐L1 CPS across multiple indications	9
Diagnostic test accuracy meta‐analysis of PRAME in distinguishing primary cutaneous melanomas from benign melanocytic lesions	9
Switch/sucrose‐non‐fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)‐deficient colorectal carcinomas are strongly associa	9
Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2‐tier nuclear grade	9
Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma	9
Biliary intraductal tubule‐forming neoplasm: a whole exome sequencing study of MUC5AC‐positive and ‐negative cases	9
Epstein–Barr virus‐positive inflammatory follicular dendritic cell sarcoma presenting as a solitary colonic mass: two rare cases and a literature review	9
Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods	9
Mesonephric‐like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas	9
Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer	9
Immunohistochemical detection of citrullinated histone H3‐positive neutrophils is useful for identifying active glomerular and interstitial lesions in antineutrophil cytoplasmic antibody‐associated va	9
SWI/SNF protein and claudin‐4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum	9
Concordance between core needle biopsy and surgical excision specimens for Ki‐67 in breast cancer – a systematic review of the literature	9
Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiation	9
Molecular and immunohistochemical characterisation of mesothelioma of the tunica vaginalis*	9
Establishing diagnostic criteria for mastocytosis in skin biopsies	9
The solid variant of papillary thyroid carcinoma: a multi‐institutional retrospective study	9
Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach	9
A simple digital image analysis system for automated Ki67 assessment in primary breast cancer	9
The utility of artificial intelligence in the assessment of prostate pathology	9
A systematic comparison ofpan‐Trkimmunohistochemistry assays among multiple cancer types	9
DNA mismatch repair‐deficient non‐neoplastic endometrial glands are common in Lynch syndrome patients and are present at a higher density than in the colon	8
Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early‐stage luminal breast cancer	8
Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms	8
Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study	8
Risk factors for progression of appendiceal neuroendocrine tumours: low‐stage tumours <5 mm appear to be overwhelmingly indolent and may merit a separate designation	8
Epithelioid sarcoma with retained INI1 (SMARCB1) expression	8
Is nestin a diagnostic marker for combined hepatocellular–cholangiocarcinoma?	8
Infectious diseases of the upper gastrointestinal tract	8
ALK rearrangement in a gastrointestinal stromal tumour of the small bowel	8
Artificial intelligence in breast cancer histopathology	8
Recent developments in gastroesophageal mesenchymal tumours	8